Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Arranta Bio
Arranta Bio
Activities:
Ingredients
Research & Development
Digestion
X
LinkedIn
Trending Articles
Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility
The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms
You need to be a subscriber to read this article.
Click here
to find out more.
CDMO insights: development and manufacture of a highly potent OSD product
In today’s pharmaceutical landscape, contract development and manufacturing organisations (CDMOs) are ubiquitous. Prior to the CDMO boom in the 1990s, however, this wasn’t...
Gerresheimer acquires Bormioli Pharma Group through Blitz LuxCo Sarl merger
Gerresheimer and Bormioli Pharma will merge to provide the biotech and pharmaceutical industries with primary packaging solutions, dosing systems, closure solutions and...
Accumulus Synergy teams up with CEPI to expedite the vaccine regulatory approval process
Through Accumulus' cloud-based technology, the two organisations aim to accelerate the accessibility of data for the regulatory approval process of vaccines globally, enhancing...
Manufacturing Chemist Stand Side with Enzene Biosciences at CPHI Milan 2024
We discover what exhibitors at CPHI Milan 2024 are showcasing LIVE!
Upcoming event
EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications
16 January 2025 | Virtual
See all
Related Content
Drug Delivery
Arranta Bio signs contract for continuous mRNA manufacturing tech
The contract with the CDMO is part of the FDA’s initiative to have a fully integrated, continuous manufacturing production line for mRNA vaccines
Ingredients
Arranta Bio completes sale of Florida site
The company has completed the sale of its Floria site and progress on $150M investment plan to expand development and commercial manufacturing services
Ingredients
New microbiome specialist raises $82m and partners with Thermo Fisher
Arranta Bio will have access to Thermo Fisher’s full suite of products and services and will provide materials to Thermo Fisher for use in gene therapy production
Subscribe now